Wall Street Experts
ver. ZuMIgo(08/25)
Prognozy (mln) dla Shenyang Xingqi Pharmaceutical Co.,Ltd
| Okres |
2023-12-31 |
2024-12-31 |
2025-12-31 |
2026-12-31 |
| Przychód (średnia) |
1,481.00 |
3,529.50 |
5,524.50 |
7,325.00 |
| Przychód Δ r/r |
0.00% |
138.32% |
56.52% |
32.59% |
| Przychód (min) |
1,481.00 |
3,529.50 |
5,524.50 |
7,325.00 |
| Przychód (max) |
1,481.00 |
3,529.50 |
5,524.50 |
7,325.00 |
| EBITDA (średnia) |
351.32 |
837.27 |
1,310.52 |
1,737.63 |
| EBIT (średnia) |
249.64 |
594.94 |
931.23 |
1,234.73 |
| EBIT % |
16.86% |
16.86% |
16.86% |
16.86% |
| Zysk netto (średni) |
186.56 |
650.28 |
1,089.13 |
1,456.47 |
| Zysk netto % |
12.60% |
18.42% |
19.71% |
19.88% |
| EPS (średnia) |
1.50 |
5.23 |
8.76 |
11.71 |
| Liczba analityków (Przychody) |
1 |
1 |
1 |
0 |
| Liczba analityków (EPS) |
1 |
1 |
1 |
0 |
| symbol |
300573.SZ |
300573.SZ |
300573.SZ |
300573.SZ |